Our Latest Stories

Your Health
April 11, 2025
More to the Story of CIDP: a Complex Neuromuscular Condition

United by Purpose
Each of us plays a unique role in bringing our purpose to life.
About Us

Who We Are
We are an innovative global healthcare company.
Our Pipeline
5
Therapeutic areas
83
Compounds in clinical development
26
Clinical trials in phase 3

Pursue Progress. Discover Extraordinary.
Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.
Our Latest Press Releases
April 18, 2025
Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria
April 15, 2025
Press Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD
April 8, 2025
Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
April 3, 2025
Press Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines